NDC 72934-1211

011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5%

011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5%

011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Niacinamide; Spironolactone; Dapsone.

• Product ID: 72934-1211_a97a5200-06df-1fad-e053-2a95a90a996d
• NDC: 72934-1211
• Product Type: Human Prescription Drug
• Proprietary Name: 011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5%
• Generic Name: 011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5%
• Dosage Form: Gel
• Route of Administration: TOPICAL
• Marketing Start Date: 2020-07-02
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: NIACINAMIDE; SPIRONOLACTONE; DAPSONE
• Active Ingredient Strength: 2 g/100g; g/100g; g/100g
• Pharm Classes: Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Sulfone [EPC],Sulfones [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 72934-1211-2

30 g in 1 BOTTLE, PUMP (72934-1211-2)

• Marketing Start Date: 2020-07-02
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details